{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:03:02Z","timestamp":1789722182034,"version":"4.0.1"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Hantaviruses are emerging rodent-borne zoonotic viruses that continue to pose a public health concern despite their relatively low incidence in humans. The 2026\n                      <jats:italic>Andes virus<\/jats:italic>\n                      outbreak linked to the MV\n                      <jats:italic>Hondius<\/jats:italic>\n                      cruise ship renewed international attention on these pathogens, highlighting unresolved questions regarding transmission dynamics, vulnerable populations, and global preparedness. This review provides an updated critical appraisal of recent advances in hantavirus epidemiology, emerging therapeutic strategies, and public health challenges, with particular emphasis on the 2026 Andes virus outbreak, companion animals, and solid organ transplant recipients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A review of the recent literature was performed, focusing on zoonotic transmission, the role of companion animals, current and emerging therapeutic strategies, infections in immunocompromised and solid-organ transplant recipients, and the implications of the 2026 international outbreak.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Although the sentinel hypothesis remains plausible, companion animals are not natural reservoirs, and preliminary evidence suggests that their exposure may reflect local hantavirus circulation, while pet rats have emerged as an important source of\n                      <jats:italic>Seoul orthohantavirus<\/jats:italic>\n                      infection. Therapeutic options remain limited: supportive care is the standard of treatment, and ribavirin shows benefit only in early hemorrhagic fever with renal syndrome. Emerging immunotherapeutic approaches, including neutralizing monoclonal antibodies and host-directed therapies, show promising preclinical results but still lack robust clinical validation. In immunocompromised patients, particularly solid-organ transplant recipients, hantavirus infection may mimic graft rejection or present with atypical, potentially fatal manifestations, posing diagnostic challenges. The 2026\u00a0MV\n                      <jats:italic>Hondius<\/jats:italic>\n                      outbreak reinforced the need for heightened surveillance, rapid diagnosis, and coordinated international response, while confirming that sustained human-to-human transmission remains exceptional.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Recent evidence broadens the clinical and public health relevance of hantaviruses beyond their traditional framing as rodent-borne zoonoses. Advances in targeted therapeutics, integrated surveillance, and One Health preparedness will be pivotal to improving outbreak preparedness and accelerating the development of effective preventive and therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1925640","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:34:07Z","timestamp":1789720447000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hantavirus as a persistent zoonotic risk: epidemiology and current pharmacological management"],"prefix":"10.3389","volume":"17","author":[{"given":"Salvatore","family":"Di Maria","sequence":"first","affiliation":[{"name":"School of Specialization in Hospital Pharmacy, University of Catania","place":["Catania, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Provenzani","sequence":"additional","affiliation":[{"name":"IRCCS ISMETT","place":["Palermo, Italy"]},{"name":"UPMC Italy","place":["Palermo, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1233433","DOI":"10.3389\/fmicb.2023.1233433","article-title":"Hantavirus: an overview and advancements in therapeutic approaches for infection","volume":"14","author":"Afzal","year":"2023","journal-title":"Front. Microbiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3855\/jidc.317","article-title":"Hantavirus infection: a review and global update","volume":"2","author":"Bi","year":"2008","journal-title":"J. Infect. Dev. Ctries."},{"key":"B3","doi-asserted-by":"publisher","first-page":"001998","DOI":"10.1099\/jgv.0.001998","article-title":"ICTV virus taxonomy profile: hantaviridae 2024","volume":"105","author":"Bradfute","year":"2024","journal-title":"J. Gen. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3390\/v11070610","article-title":"Progress on the prevention and treatment of hantavirus disease","volume":"11","author":"Brocato","year":"2019","journal-title":"Viruses"},{"key":"B5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/pch\/5.2.119","article-title":"Healthy pets, healthy people: how to avoid the diseases that pets can spread to people","volume":"5","year":"2000","journal-title":"Paediatr. Child. Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s44358-024-00005-w","article-title":"Pathogens and planetary change","volume":"1","author":"Carlson","year":"2025","journal-title":"Nat. Rev. Biodivers."},{"key":"B7","volume-title":"Clinician Brief: Hemorrhagic Fever with Renal Syndrome (HFRS)","year":"2024"},{"key":"B8","volume-title":"Clinician Brief: Hantavirus Pulmonary Syndrome (HPS)","year":"2026"},{"key":"B9","doi-asserted-by":"publisher","first-page":"106091","DOI":"10.1016\/j.ebiom.2025.106091","article-title":"Cross-binding antibodies capable of neutralising diverse hantaviruses are produced in response to Puumala virus infection","volume":"124","author":"Clark","year":"2026","journal-title":"EBioMedicine"},{"key":"B10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.3390\/v11070652","article-title":"Wild rats, laboratory rats, pet rats: global Seoul hantavirus disease revisited","volume":"11","author":"Clement","year":"2019","journal-title":"Viruses"},{"key":"B11","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s40506-020-00236-3","article-title":"Hantavirus infections: treatment and prevention","volume":"12","author":"Dheerasekara","year":"2020","journal-title":"Curr. Treat. Options Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.rvsc.2011.02.003","article-title":"Sero-epidemiological study of the presence of hantaviruses in domestic dogs and cats from Belgium","volume":"92","author":"Dobly","year":"2012","journal-title":"Res. Vet. Sci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e00028-20","DOI":"10.1128\/mBio.00028-20","article-title":"Neutralizing monoclonal antibodies against the Gn and the Gc of the Andes virus glycoprotein spike complex protect from virus challenge in a preclinical hamster model","volume":"11","author":"Duehr","year":"2020","journal-title":"mBio"},{"key":"B14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s42522-025-00136-w","article-title":"Ecological determinants driving orthohantavirus prevalence in small mammals of Europe: a systematic review","volume":"7","author":"Fabbri","year":"2025","journal-title":"One Health Outlook"},{"key":"B15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S1473-3099(24)00142-7","article-title":"Viral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study","volume":"24","author":"Ferr\u00e9s","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.cell.2026.01.030","article-title":"High-resolution in situ structures of hantavirus glycoprotein tetramers","volume":"189","author":"Guo","year":"2026","journal-title":"Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"4976","DOI":"10.3390\/v7092861","article-title":"Hantavirus structure, regulation and function of the viral RNA","volume":"7","author":"Hepojoki","year":"2015","journal-title":"Viruses"},{"key":"B19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/v15020467","article-title":"Pet rats as the likely reservoir for human Seoul orthohantavirus infection","volume":"15","author":"Heuser","year":"2023","journal-title":"Viruses"},{"key":"B20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3390\/vaccines8030377","article-title":"A phase 2a randomized, double-blind, dose-optimizing study to evaluate the immunogenicity and safety of a bivalent DNA vaccine for hemorrhagic fever with renal syndrome delivered by intramuscular electroporation","volume":"8","author":"Hooper","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J. Infect. Dis."},{"key":"B22","volume-title":"Hantavirus","year":"2026"},{"key":"B23","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s11262-018-1590-z","article-title":"Reassortment events in the evolution of hantaviruses","volume":"54","author":"Klempa","year":"2018","journal-title":"Virus Genes"},{"key":"B24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5005\/jp-journals-10071-25215","article-title":"Hantavirus: a comprehensive contemporary review of virology, global epidemiology, clinical variants, diagnosis, treatment, and intensive care management","volume":"30","author":"Kumar","year":"2026","journal-title":"Indian J. Crit. Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e70365","DOI":"10.1111\/cbdd.70365","article-title":"Advancing antiviral design: integrating natural products, computation and targeted delivery","volume":"108","author":"Lanrewaju","year":"2026","journal-title":"Chem. Biol. Drug Des."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.3389\/fmicb.2019.02989","article-title":"Vaccines and therapeutics against hantaviruses","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1458112","DOI":"10.3389\/fviro.2024.1458112","article-title":"Host-directed antiviral therapeutics and the NIAID research agenda: an underexplored frontier","volume":"4","author":"Martin","year":"2024","journal-title":"Front. Virol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa2009040","article-title":"Super-spreaders and person-to-person transmission of Andes virus in Argentina","volume":"383","author":"Mart\u00ednez","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.3201\/eid2010.140353","article-title":"Person-to-person household and nosocomial transmission of Andes hantavirus, Southern Chile, 2011","volume":"20","author":"Martinez-Valdebenito","year":"2014","journal-title":"Emerg. Infect. Dis."},{"key":"B30","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1017\/S0950268817001819","article-title":"High prevalence of Seoul hantavirus in a breeding colony of pet rats","volume":"145","author":"McElhinney","year":"2017","journal-title":"Epidemiol. Infect."},{"key":"B31","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1399-3062.2006.00193.x","article-title":"Acute hantavirus infection or renal transplant rejection","volume":"9","author":"Meier","year":"2007","journal-title":"Transpl. Infect. Dis."},{"key":"B32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s13337-014-0219-7","article-title":"Effectiveness of ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis","volume":"25","author":"Moreli","year":"2014","journal-title":"Virusdisease"},{"key":"B33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/1440-1681.13403","article-title":"Hantavirus diseases pathophysiology, their diagnostic strategies and therapeutic approaches: a review","volume":"48","author":"Munir","year":"2021","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2217\/fvl-2018-0166","article-title":"Ribavirin: pharmacology, multiple modes of action and possible future perspectives","volume":"14","author":"Nystr\u00f6m","year":"2019","journal-title":"Future Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e20260871","DOI":"10.1084\/jem.20260871","article-title":"Hantavirus disease and the need for pathogenesis-guided therapy","volume":"223","author":"Paludan","year":"2026","journal-title":"J. Exp. Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/infdis\/jiad235","article-title":"Safety and immunogenicity of an Andes virus DNA vaccine by needle-free injection: a randomized, controlled phase 1 study","volume":"229","author":"Paulsen","year":"2024","journal-title":"J. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/j.ajt.2026.05.2295","article-title":"World Health Organization\u2014Hantavirus cluster linked to cruise ship travel, multicountry","volume":"26","author":"Pereira","year":"2026","journal-title":"Am. J. Transpl."},{"key":"B38","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nrmicro.2017.45","article-title":"Pathways to zoonotic spillover","volume":"15","author":"Plowright","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s11096-020-01049-6","article-title":"Covid-19 and drug therapy, what we learned","volume":"42","author":"Provenzani","year":"2020","journal-title":"Int. J. Clin. Pharm."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e14352","DOI":"10.1111\/tid.14352","article-title":"Central nervous system infection with hantavirus in a solid organ transplant patient","volume":"26","author":"Qin","year":"2024","journal-title":"Transpl. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/microorganisms14061326","article-title":"Hantavirus emergence in a changing world: virology, pathogenesis, surveillance, and One Health preparedness","volume":"14","author":"Ramos-Nino","year":"2026","journal-title":"Microorganisms"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.2017.17645","article-title":"Pet rats infect daughter, mother with hantavirus","volume":"318","author":"Rubin","year":"2017","journal-title":"JAMA"},{"key":"B43","doi-asserted-by":"publisher","first-page":"8041","DOI":"10.1073\/pnas.1701777114","article-title":"Interannual cycles of Hantaan virus outbreaks at the human-animal interface in Central China are controlled by temperature and rainfall","volume":"114","author":"Tian","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/infdis\/jiab461","article-title":"Evidence for human-to-human transmission of hantavirus: a systematic review","volume":"226","author":"Toledo","year":"2022","journal-title":"J. Infect. Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1186\/s12889-024-20014-w","article-title":"Seroprevalence of hantavirus infection in non-epidemic settings over four decades: a systematic review and meta-analysis","volume":"24","author":"Tortosa","year":"2024","journal-title":"BMC Public Health"},{"key":"B46","volume-title":"Incubation and Infectious Period, Asymptomatic or Presymptomatic Transmission and Transmission Route in human-to-human Spread of Hantavirus Infection: A Systematic Evidence Summary","year":"2026"},{"key":"B47","doi-asserted-by":"publisher","first-page":"154867","DOI":"10.1016\/j.jcrc.2024.154867","article-title":"Critical care management of hantavirus cardiopulmonary syndrome: a narrative review","volume":"84","author":"Ulloa-Morrison","year":"2024","journal-title":"J. Crit. Care"},{"key":"B48","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nrmicro3066","article-title":"Uncovering the mysteries of hantavirus infections","volume":"11","author":"Vaheri","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/cid\/cit394","article-title":"High-dose intravenous methylprednisolone for hantavirus cardiopulmonary syndrome in Chile: a double-blind, randomized controlled clinical trial","volume":"57","author":"Vial","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3851\/IMP2875","article-title":"A non-randomized multicentre trial of human immune plasma for treatment of hantavirus cardiopulmonary syndrome caused by Andes virus","volume":"20","author":"Vial","year":"2015","journal-title":"Antivir. Ther."},{"key":"B51","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S1473-3099(23)00128-7","article-title":"Hantavirus in humans: a review of clinical aspects and management","volume":"23","author":"Vial","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/S0140-6736(15)60901-1","article-title":"Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health","volume":"386","author":"Whitmee","year":"2015","journal-title":"Lancet"},{"key":"B53","volume-title":"Hantavirus Cluster Linked to Cruise Ship Travel, multi-country. Disease Outbreak News","year":"2026"},{"key":"B54","volume-title":"Hantavirus Disease","year":""},{"key":"B55","volume-title":"Hantavirus Cluster Linked to Cruise Ship Travel, multi-country. Disease Outbreak News","year":""},{"key":"B56","volume-title":"Hantavirus Cluster Linked to Cruise Ship Travel, multi-country. Disease Outbreak News","year":""},{"key":"B57","volume-title":"Hantavirus Outbreak Linked to Cruise Ship Travel, multi-country. Disease Outbreak News","year":""},{"key":"B58","volume-title":"Hantavirus Outbreak Toolbox","year":""},{"key":"B59","volume-title":"Management of Contacts of Andes Virus (ANDV) Cases from the MV Hondius Cruise Ship: Interim Guidance","year":""}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1925640\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:34:10Z","timestamp":1789720450000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1925640\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":59,"alternative-id":["10.3389\/fphar.2026.1925640"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1925640","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"article-number":"1925640"}}